Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICD Firms Should Report All Malfunctions To Doctors And Patients – Maisel

This article was originally published in The Gray Sheet

Executive Summary

FDA should require ICD manufacturers to publish a comprehensive annual report on device reliability and malfunction data, according to William Maisel, MD, Harvard Medical School

You may also be interested in...



Senate Probes Guidant’s Compliance With Its Corporate Integrity Agreement

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is investigating the recent series of Guidant device recalls to determine if the company violated the terms of its 2003 Corporate Integrity Agreement (CIA)

Senate Probes Guidant’s Compliance With Its Corporate Integrity Agreement

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is investigating the recent series of Guidant device recalls to determine if the company violated the terms of its 2003 Corporate Integrity Agreement (CIA)

“Passive” Adverse Event Data Inadequate, Say FDA/HRS Meeting Panelists

FDA must expand its "enhanced" adverse event reporting system and improve "passive" surveillance in order to detect rare device malfunctions, said panelists at the Policy Conference on Pacemaker and Implantable Cardioverter Defibrillator Performance in Washington, D.C. Sept. 16

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022579

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel